Why Has Big Pharma Failed At Developing a Therapeutic for Osteoarthritis?

April 10, 2019

The reason that large pharmaceutical companies have not been able to do what we’ve done is because they have adopted a very narrow approach to treating osteoarthritis (OA). Big Pharma has tried to imitate the successful discovery of a treatment for rheumatoid arthritis (RA) by looking for a single cause of OA.

Spotlight

Laboratorios Normon España

Welcome to the official LinkedIn page of Laboratorios Normon SA España, a channel created with the aim of reaching the maximum approach between the Laboratory, institutions, health professionals and organizations in Health 2.0.

OTHER VIDEOS

Free flowing amorphous solid dispersions for enhanced drug solubility

video | March 9, 2022

Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology EUDRATEC® SoluFlow is just that! It works by turning a poorly soluble drug into a free-flowing amorphous solid dispersion (ASD) that can be easily compressed into tablets or filled into capsules....

Watch Now

Optimizing Outcomes Across the Pharma Value Chain Network

video | January 20, 2022

The pharma industry faces new challenges to be more agile and flexible in the effort to produce and deliver medicines to market faster. Digitalization will play a key role in helping companies optimize their value chain network. Hear from AspenTech's David Leitham as he touches on this trend and how Industrial AI solutions will help companies stay ahead....

Watch Now

How Billionaire Mark Cuban's Online Pharmacy Went From Pitch To Reality

video | February 2, 2022

Billionaire investor Mark Cuban launched an online pharmacy that offers more than 100 generic drugs at an affordable price with a goal of being “radically transparent” in its price negotiations with drug companies....

Watch Now

Digital Health solutions for patient centric clinical trials

video | August 24, 2021

Digital health solutions for remote patient data collection and continuous patient monitoring are enabling us to reduce patient burden and accelerate our clinical trials. Halsey Lea, Director Data Science, Data Science & AI, R&D, explains the transformative role that digital connected devices are playing in our smart clinical trial programmes....

Watch Now

Spotlight

Laboratorios Normon España

Welcome to the official LinkedIn page of Laboratorios Normon SA España, a channel created with the aim of reaching the maximum approach between the Laboratory, institutions, health professionals and organizations in Health 2.0.

Events